Source: Lapham, Gwen T. PhD, MPH, MSW; Chi, Felicia W. MPH; Young-Wolff, Kelly C. PhD, MPH; Ansley, Deborah MD; Castellanos, Carley MFT; Does, Monique B. MPH; Asyyed, Asma H. MD; Ettenger, Allison MSc; Campbell, Cynthia I. PhD. Predictors of Participation in Prenatal Substance Use Assessment...

Source: Pourebrahim, S., Ahmad, T., Rottmann, E., Schulze, J., & Scheller, B. (2025). Does Cannabis Use Contribute to Schizophrenia? A Causation Analysis Based on Epidemiological Evidence. Biomolecules, 15(3), 368. https://doi.org/10.3390/biom15030368 Abstract Cannabis abuse has been linked to acute...

Fuente: Martínez-Peña, A. A. (2024). Efectos y prevalencia del consumo simultáneo de alcohol y cannabis: una revisión narrativa. Revista inteRnacional de investigación en adicciones, 10(2), 203-216. Resumen Introducción: el consumo de cannabis ha aumentado significativamente durante las últimas...

Source: McDonald, A. J., Kurdyak, P., Rehm, J., Roerecke, M., & Bondy, S. J. Age-dependent association of cannabis use with risk of psychotic disorder. Psychological Medicine, 1-11. Abstract Background Epidemiologic research suggests that youth cannabis use is associated with psychotic disorders...

Source: Dawson, D., Stjepanovic, D., Lorenzetti, V., Cheung, C., Hall, W., & Leung, J. (2024). The prevalence of cannabis use disorders in people who use medicinal cannabis: a systematic review and meta-analysis. Drug and Alcohol Dependence, 111263. Highlights -The prevalence of cannabis use...

Source: Jeffers, A. M., Glantz, S., Byers, A. L., & Keyhani, S. (2024). Association of Cannabis Use With Cardiovascular Outcomes Among US Adults. Journal of the American Heart Association, e030178. Abstract Background We examined the association between cannabis use and cardiovascular outcomes among...

Source: Myran DT, Gaudreault A, Konikoff L, Talarico R, Liccardo Pacula R. Changes in Cannabis-Attributable Hospitalizations Following Nonmedical Cannabis Legalization in Canada. JAMA Netw Open. 2023;6(10):e2336113. doi:10.1001/jamanetworkopen.2023.36113 Key Points Question How have rates of...

Source: Oliver, D., Englund, A., Chesney, E., Chester, L., Wilson, J., Sovi, S., ... & McGuire, P. (2023). Cannabidiol does not attenuate acute delta-9-tetrahydrocannabinol-induced attentional bias in healthy volunteers: A randomised, double-blind, crossover study. Addiction. Abstract Aims To test...

Source: Roberts SCM, Zaugg C, Biggs MA. Association of Mandatory Warning Signs for Cannabis Use During Pregnancy With Cannabis Use Beliefs and Behaviors. JAMA Netw Open. 2023;6(6):e2317138. doi:10.1001/jamanetworkopen.2023.17138 Key Points Question Are policies mandating warning signs regarding the...

Source: Shao, H., Du, H., Gan, Q., Ye, D., Chen, Z., Zhu, Y., Zhu, S., Qu, L., Lu, J., Li, Y., Duan, J., Gu, Y., & Chen, M. (2023). Trends of the Global Burden of Disease Attributable to Cannabis Use Disorder in 204 Countries and Territories, 1990-2019: Results from the Disease Burden Study 2019...

Source: Arkell TR, Downey LA, Hayley AC, Roth S. Assessment of Medical Cannabis and Health-Related Quality of Life. JAMA Netw Open. 2023;6(5):e2312522. doi:10.1001/jamanetworkopen.2023.12522 Key Points Question Is medical cannabis treatment associated with improvements in health-related quality of...

Source: Hjorthøj, C., Compton, W., Starzer, M., Nordholm, D., Einstein, E., Erlangsen, A., . . . Han, B. (2023). Association between cannabis use disorder and schizophrenia stronger in young males than in females. Psychological Medicine, 1-7. doi:10.1017/S0033291723000880 Abstract Background...

Source: Sultan RS, Zhang AW, Olfson M, Kwizera MH, Levin FR. Nondisordered Cannabis Use Among US Adolescents. JAMA Netw Open. 2023;6(5):e2311294. doi:10.1001/jamanetworkopen.2023.11294 Key Points Question Is nondisordered cannabis use (NDCU) among US adolescents associated with adverse psychosocial...

Source: Stith, S., Pearson, J., Brockelman, F., Keeling, K., Hall, B., & Friedman, A. (2023). Nationally Representative Surveys on Cannabis Use Lack Product Details Relevant to Public Health. Drug and Alcohol Dependence Reports, 100134. Highlights •Nationally representative surveys measure cannabis...

Source: Gedin F, Blomé S, Pontén M, et al. Placebo Response and Media Attention in Randomized Clinical Trials Assessing Cannabis-Based Therapies for Pain: A Systematic Review and Meta-analysis. JAMA Netw Open. 2022;5(11):e2243848. doi:10.1001/jamanetworkopen.2022.43848 Key Points Question What is...

Source: Englund, A., Oliver, D., Chesney, E. et al. Does cannabidiol make cannabis safer? A randomised, double-blind, cross-over trial of cannabis with four different CBD:THC ratios. Neuropsychopharmacol. (2022). https://doi.org/10.1038/s41386-022-01478-z Abstract As countries adopt more permissive...

Source: Myran DT, Roberts R, Pugliese M, Taljaard M, Tanuseputro P, Pacula RL. Changes in Emergency Department Visits for Cannabis Hyperemesis Syndrome Following Recreational Cannabis Legalization and Subsequent Commercialization in Ontario, Canada. JAMA Netw Open. 2022;5(9):e2231937. doi:10.1001...

Source: Conde K, Peltzer RI, Gimenez PV, Salomón T, Suarez G, Monteiro M et al. Road traffic injury risk from alcohol and cannabis use among emergency department patients in Argentina. Rev Panam Salud Publica. 2022;46:e116. https://doi.org/10.26633/ RPSP.2022.116 ABSTRACT Objective. To report the...

Source: Callaghan, R. C., Sanches, M., Murray, R. M., Konefal, S., Maloney-Hall, B., & Kish, S. J. (2022). Associations Between Canada's Cannabis Legalization and Emergency Department Presentations for Transient Cannabis-Induced Psychosis and Schizophrenia Conditions: Ontario and Alberta, 2015–2019...